VEGF-A is the most pro-angiogenic cytokine in MM: it is a regulator of the cell growth, survival and migration of ECs through VEGFR-2; in contrast, when acting through VEGFR-1, it regulates the growth of BMSCs. The gene discussed is FLT1; the disease is Miyoshi myopathy.